Anson Funds Management’s OncoSec Medical ONCS Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCS
6CM
Anson Funds Management's ONCS Position: Q1 2019 in Review
Anson Funds Management sold out of OncoSec Medical (ONCS) in Q1 2019, closing a stake of 2,925 shares — an estimated $412K sold.
Anson Funds Management first reported a position in ONCS in Q4 2016 and held it in 2 quarters. The position peaked at $412K in Q4 2018. 30 funds tracked by Wall St. Rank hold ONCS as of Q1 2019.
- Anson Funds Management reported no remaining OncoSec Medical position as of Q1 2019 after selling out during the quarter.
- Anson Funds Management sold 2,925 OncoSec Medical shares in Q1 2019, an estimated $412K.
- Anson Funds Management first reported a position in OncoSec Medical in Q4 2016 and held it in 2 quarters.
- Anson Funds Management's OncoSec Medical position peaked at $412K in Q4 2018.
- 30 funds tracked by Wall St. Rank held OncoSec Medical as of Q1 2019.
Based on Anson Funds Management's 13F filing for Q1 2019, filed 15 May 2019.